Broadcom Inc (AVGO)
163.78
-0.16
(-0.10%)
USD |
NASDAQ |
Nov 22, 10:49
Broadcom R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical R&D to Revenue (TTM) Data
| Date | Value |
|---|---|
| July 31, 2024 | -- |
| April 30, 2024 | -- |
| January 31, 2024 | -- |
| October 31, 2023 | -- |
| July 31, 2023 | -- |
| April 30, 2023 | -- |
| January 31, 2023 | -- |
| October 31, 2022 | -- |
| July 31, 2022 | -- |
| April 30, 2022 | -- |
| January 31, 2022 | -- |
| October 31, 2021 | -- |
| July 31, 2021 | -- |
| April 30, 2021 | -- |
| January 31, 2021 | -- |
| October 31, 2020 | -- |
| July 31, 2020 | -- |
| April 30, 2020 | -- |
| January 31, 2020 | -- |
| October 31, 2019 | -- |
| July 31, 2019 | -- |
| April 30, 2019 | -- |
| January 31, 2019 | -- |
| October 31, 2018 | -- |
| July 31, 2018 | -- |
| Date | Value |
|---|---|
| April 30, 2018 | -- |
| January 31, 2018 | -- |
| October 31, 2017 | -- |
| July 31, 2017 | -- |
| April 30, 2017 | -- |
| January 31, 2017 | -- |
| October 31, 2016 | -- |
| July 31, 2016 | -- |
| April 30, 2016 | -- |
| January 31, 2016 | -- |
| October 31, 2015 | -- |
| July 31, 2015 | -- |
| April 30, 2015 | -- |
| January 31, 2015 | -- |
| October 31, 2014 | -- |
| July 31, 2014 | -- |
| April 30, 2014 | -- |
| January 31, 2014 | -- |
| October 31, 2013 | -- |
| July 31, 2013 | -- |
| April 30, 2013 | -- |
| January 31, 2013 | -- |
| October 31, 2012 | -- |
| July 31, 2012 | -- |
| April 30, 2012 | -- |
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.